Resonant Capital Advisors LLC Grows Stake in Danaher Co. (NYSE:DHR)

Resonant Capital Advisors LLC boosted its position in shares of Danaher Co. (NYSE:DHR) by 0.6% during the 4th quarter, HoldingsChannel reports. The firm owned 13,652 shares of the conglomerate’s stock after buying an additional 75 shares during the period. Resonant Capital Advisors LLC’s holdings in Danaher were worth $3,138,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. AMF Tjanstepension AB acquired a new stake in shares of Danaher in the 3rd quarter worth $5,923,000. Czech National Bank boosted its position in shares of Danaher by 4.2% in the 3rd quarter. Czech National Bank now owns 130,939 shares of the conglomerate’s stock worth $36,404,000 after purchasing an additional 5,320 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Danaher by 33.5% in the 3rd quarter. GAMMA Investing LLC now owns 4,480 shares of the conglomerate’s stock worth $1,246,000 after purchasing an additional 1,125 shares in the last quarter. WealthBridge Capital Management LLC lifted its position in Danaher by 51.8% during the 3rd quarter. WealthBridge Capital Management LLC now owns 1,465 shares of the conglomerate’s stock worth $407,000 after acquiring an additional 500 shares during the period. Finally, Diversified Trust Co lifted its position in Danaher by 29.6% during the 3rd quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock worth $1,571,000 after acquiring an additional 1,289 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have commented on the company. Robert W. Baird lowered their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. JPMorgan Chase & Co. cut their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Scotiabank started coverage on Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective on the stock. KeyCorp boosted their target price on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, October 23rd. Finally, Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a report on Friday, December 13th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders own 10.90% of the company’s stock.

Danaher Stock Performance

NYSE DHR opened at $222.56 on Monday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a 1 year low of $221.34 and a 1 year high of $281.70. The company has a market capitalization of $160.75 billion, a PE ratio of 42.15, a P/E/G ratio of 2.80 and a beta of 0.83. The company has a fifty day moving average of $235.40 and a two-hundred day moving average of $253.09.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the prior year, the firm earned $2.09 earnings per share. As a group, analysts expect that Danaher Co. will post 7.77 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were paid a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.49%. Danaher’s dividend payout ratio (DPR) is 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.